rdf:type |
|
lifeskim:mentions |
umls-concept:C0020975,
umls-concept:C0021294,
umls-concept:C0031603,
umls-concept:C0035526,
umls-concept:C0062086,
umls-concept:C0205195,
umls-concept:C0205225,
umls-concept:C0206435,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-1-3
|
pubmed:abstractText |
Prematurity may be a risk factor for Haemophilus influenzae type b vaccine failure. This article evaluates the Haemophilus influenzae type b immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus/Haemophilus influenzae type b vaccine in preterm infants (< 37 weeks' gestation).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Capsules,
http://linkedlifedata.com/resource/pubmed/chemical/DTPa-HBV-IPV combined vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria-Tetanus-Pertussis Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Haemophilus Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Haemophilus influenzae type b...,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Poliovirus Vaccine, Inactivated,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Combined,
http://linkedlifedata.com/resource/pubmed/chemical/polyribitol phosphate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1098-4275
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e179-85
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17145903-Antibody Formation,
pubmed-meshheading:17145903-Bacterial Capsules,
pubmed-meshheading:17145903-Birth Weight,
pubmed-meshheading:17145903-Diphtheria-Tetanus-Pertussis Vaccine,
pubmed-meshheading:17145903-Gestational Age,
pubmed-meshheading:17145903-Haemophilus Vaccines,
pubmed-meshheading:17145903-Hepatitis B Vaccines,
pubmed-meshheading:17145903-Humans,
pubmed-meshheading:17145903-Immunization, Secondary,
pubmed-meshheading:17145903-Immunization Schedule,
pubmed-meshheading:17145903-Infant,
pubmed-meshheading:17145903-Infant, Newborn,
pubmed-meshheading:17145903-Infant, Premature,
pubmed-meshheading:17145903-Poliovirus Vaccine, Inactivated,
pubmed-meshheading:17145903-Polysaccharides,
pubmed-meshheading:17145903-Polysaccharides, Bacterial,
pubmed-meshheading:17145903-Vaccines, Combined
|
pubmed:year |
2007
|
pubmed:articleTitle |
Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
|
pubmed:affiliation |
Department of Neonatology, La Paz Hospital, Madrid, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|